Coya Therapeutics Inc (COYA) Live Share Price, Invest From India

Coya Therapeutics Inc Stock Performance

as on November 3, 2025 at 9:40 pm IST

Day's Low
Day's High
$6.11
Day's Price Range
$6.33
$6.15
0.65%
Downside
2.93%
Upside
52 Week's Low
52 Week's High
$4.65
52-Week Price Range
$8.29
$6.15
24.39%
Downside
34.80%
Upside

Coya Therapeutics Inc share price movements today

Previous Close: $6.32
Open: $6.33
Volume: 35.2K
Day's Low - High: $6.11 - $6.33
52 Week Low - High: $4.65 - $8.29

Coya Therapeutics Inc Historical Returns

1 Month Return: + 3.6 %
3 Month Return: + 3.78 %
1 Year Return: -10.23 %
3 Year Return: 0 %
5 Year Return: 0 %

Coya Therapeutics Inc Stock Fundamentals & Key Indicators

Check Coya Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$132.2M

EPS (TTM)

-1.4925

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-22.6M

Revenue (TTM)

423.5K

Profit Margin

0.00%

Return On Equity TTM

-63.99%

Coya Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Coya Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Coya Therapeutics Inc	BUY	$132.2M	NA	NA	0.00%
Insmed Incorporated	BUY	$40.4B	478.23%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$60.2B	253.38%	1425.12	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$109.1B	101.56%	30.31	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$68.5B	16.98%	15.62	32.13%

Stock Returns calculator for Coya Therapeutics Inc Stock including INR - Dollar returns

The Coya Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Coya Therapeutics Inc investment value today

Current value as on today

₹93,059

Returns

₹6,941

(-6.94%)

Returns from Coya Therapeutics Inc Stock

₹12,642 (-12.64%)

Dollar Returns*

₹5,701 (+5.7%)

Analyst Recommendation on Coya Therapeutics Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Coya Therapeutics Inc. Average target price of $15.79

Coya Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Coya Therapeutics Inc.

What analysts predicted

61.05%UPSIDE

Target Price

$15.79

Current Price

$6.15

Analyzed by

8 Analysts

Target

$15.79

Coya Therapeutics Inc target price $15.79, a slight upside of 61.05% compared to current price of $6.15. According to 8 analysts rating.

Coya Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Coya Therapeutics Inc Stock has increased by 7% in the last 30 days, reflecting an upward trend in search activity.

Time period: October 4, 2025 to November 3, 2025

Change:7% versus previous 30 day period

Coya Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	6	0	3	-	0	0	0
Gross Profit	0	0	0	5	0	3	0	0	0	0
Operating Income	-2	-3	-3	1	-5	-3	-4	-4	-7	-6,414
EBITDA	-2	-3	-3	1	-5	-3	-4	-4	-7	-6,414
Interest Expense	1	-	-	0	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-2	-3	-3	1	-5	-2	-4	-3	-7	-6,094
Income Tax Expense	0	0	0	0	0	-	0	0	720	-
Net Income	-2	-3	-3	1	-5	-2	-4	-2	-7	-6,094
Net Profit Margin	0.00%	0.00%	0.00%	21.09%	-3983.03%	-84.44%	0.00%	-149385.25%	-2833.44%	-3725171.74%

Coya Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	6	3
Gross Profit	0	0	6	3
Operating Income	-4	-9	-7	-17
EBITDA	-4	-12	-7	-17
Interest Expense	0	2	-	-
Depreciation	0	0	0	0
Income Before Tax	-4	-12	-7	-15
Income Tax Expense	0	2	0	0
Net Income	-4	-12	-7	-14
Net Profit Margin	0.00%	0.00%	-133.09%	-418.71%

Coya Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-3	-3	1	-5	-2	-4	-2	-7	-6,094
Operating Cash Flow	-2	-2	-2	2	-4	-5	-2	-2,828	-5,773
Investing Cash Flow	0	-	0	0	-	-	-	-24	-
Financing Cash Flow	-	-	24	1	5	0	9	19	-
Change in Cash	-3	-2	21	3	0	-5	7	-2,809	-5,773

Coya Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-4	-12	-7	-14
Operating Cash Flow	-3	-7	-11	-10
Investing Cash Flow	0	0	0	0
Financing Cash Flow	0	9	38	16
Change in Cash	-4	1	26	5

Insights on Coya Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, COYA stock has moved up by 3.6%
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 177.5% return, outperforming this stock by 187.7%

About Coya Therapeutics Inc

Coya Therapeutics, Inc. is a clinical-stage biotechnology company, which is engaged in developing treatments focused on the biology and potential therapeutic advantages of regulatory T cells (Tregs) to target systemic inflammation and neuroinflammation. Its initial developmental programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases of high unmet medical need. Its diversified candidate pipeline includes both ex vivo and in vivo approaches. Its product candidate pipeline is based on its three therapeutic modalities. The product candidates utilizing its Treg-enhancing biologics are collectively referred to as the 300 Series. The product candidates utilizing its Treg-derived exosomes are collectively referred to as the 200 Series. The product candidates utilizing its autologous Treg cell therapy are collectively referred to as the 100 Series. The Company's 300 Series product candidates include COYA 301 and COYA 302.

Organisation	Coya Therapeutics Inc
Headquarters	5850 San Felipe St., Houston, TX, United States, 77057
CEO	Dr. Arun Swaminathan Ph.D.
E-voting on shares	Click here to vote

Key Management of Coya Therapeutics Inc

Name	Title
Dr. Arun Swaminathan Ph.D.	CEO & Director
Dr. Fred Grossman D.O., FAPA	President & Chief Medical Officer
Mr. David S. Snyder	CFO & COO
Mr. Aaron Thome Ph.D.	Head of Neuroinflammation Platform
Dr. Michelle Frazier Ph.D.	Senior Vice President of Regulatory
Ms. Karen King M.S.	Senior VP of Program Management & Clinical Operations
Dr. Howard H. Berman Ph.D.	Executive Chair

FAQs

What is Coya Therapeutics Inc share price today?

Coya Therapeutics Inc share price today is $6.15 as on November 3, 2025 at 9:40 pm IST. Coya Therapeutics Inc share today touched a day high of $6.33 and a low of $6.11.

What is the 52 week high and 52 week low for Coya Therapeutics Inc share?

Coya Therapeutics Inc share touched a 52 week high of $8.29 on March 3, 2025 and a 52 week low of $4.65 on April 9, 2025. Coya Therapeutics Inc stock price today i.e. November 3, 2025 at 9:40 pm IST is trending at $6.15,which is 25.81% down from its 52 week high and 32.26% up from its 52 week low.

What is Coya Therapeutics Inc's market capitalisation today?

Coya Therapeutics Inc market capitalisation is $0.00T as on November 3, 2025 at 9:40 pm IST.

How to invest in Coya Therapeutics Inc Stock (COYA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Coya Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Coya Therapeutics Inc Shares that will get you 0.2439 shares as per Coya Therapeutics Inc share price of $6.15 per share as on November 3, 2025 at 9:40 pm IST.

What is the minimum amount required to buy Coya Therapeutics Inc Stock (COYA) from India?

Indian investors can start investing in Coya Therapeutics Inc (COYA) shares with as little as ₹88.715 or $1 (as of November 3, 2025 at 9:43 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹887.15 in Coya Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on November 3, 2025 at 9:43 pm IST). Based on Coya Therapeutics Inc share’s latest price of $6.15 as on November 3, 2025 at 9:40 pm IST, you will get 1.6260 shares of Coya Therapeutics Inc. Learn more about fractional shares .